NeurAxis, Inc.
NRXSNYSEAMERICANHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $89.69M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.21$9.33
- Volume (live)
- -
- Avg. volume (3M)
- 183.11K
NeurAxis (NRXS) Stock Price & Financial Analysis
NeurAxis Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.42 - $7.63 |
|---|---|
| 52-Week High | $9.33 |
| 52-Week Low | $2.21 |
| Open | $7.63 |
| Volume (last close) | 75.21K |
| Average Volume (3M) | 183.11K |
| Revenue (TTM) | 5.32M |
|---|---|
| Net Income (TTM) | -7.68M |
| Free Cash Flow (TTM) | -5.63M |
| EPS (TTM) | −$0.73 |
| Profit Margin | -144.44% |
| Operating Margin | -144.51% |
| Return on Equity (ROE) | -114.01% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 89.69M |
|---|---|
| Shares Outstanding | 12.12M |
| Price to Sales (P/S) | 16.87 |
| Price to Book (P/B) | 13.32 |
| EV/EBITDA | -11.20 |
| 50-Day MA | $6.65 |
|---|---|
| 200-Day MA | $6.56 |
| 1-Year Change | +98.95% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
NeurAxis at a Glance
As of the Oct 23, 2026 close, NeurAxis (NRXS) has a market capitalization of $89.69M. The stock trades at 16.9× sales. Over the trailing twelve months it lost $7.68M on revenue of $5.32M and burned $5.63M of free cash flow. Revenue grew 65.2% year over year.
As of its latest reported balance sheet, it holds $8.32M in cash and securities against $207.45K of debt, a net cash position of $8.11M.
NeurAxis does not currently pay a dividend.
The share price is up 99.0% over the past year. At $7.40 (the Oct 23, 2026 close) it sits within its 52-week range of $2.21 to $9.33, above its 200-day moving average of $6.56.
Frequently Asked Questions About NeurAxis
What is the current stock price for NRXS?
As of the Oct 23, 2026 close, NRXS stock trades at $7.40. The 52-week range is $2.21–$9.33, with a day range of $7.42–$7.63.
What is the P/E ratio for NRXS?
The P/E ratio (Price-to-Earnings) for NRXS is shown in the Key Statistics section. This valuation metric helps compare NeurAxis, Inc. to industry peers.
Does NRXS pay dividends?
NeurAxis does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NRXS?
Analyst ratings and recommendations for NRXS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NRXS?
As of the Oct 23, 2026 close, NeurAxis's market capitalization is $89.7M, classifying it as a micro-cap company. NeurAxis operates in the Healthcare sector within the Biotechnology industry.